[1] Paulino AC,Thorstad WL,Fox T.Role of fusion in radiotherapy treatment planning[J].Semin Nucl Med,2003,33(3):238-243.
[2] Ten Haken R,Thornton A, Sandler H, et al. A quantitative assessment of the addition of MRI to CT-based 3D treatment planning of brain tumors[J].Radiother Oncol,1992,25(9):121-133.
[3] Khoo V,Adams E,Saran F,et al.A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas[J].Int J Radiat Oncol Biol Phys,2000,46(5):1309-1317.
[4] Weltens C,Menten J,Feron M,et al.Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging[J].Radiother Oncol,2001,60(1):49-59.
[5] Sannazzari GL,Ragona R,Redda MG,et al.CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer[J].Br J Radiol,2002,75(895):603-607.
[6] Ciernik IF,Dizendorf E,Baumert BG,et al.Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):a feasibility study[J].Int J Radiat Oncol Biol Phys,2003,57(3):853-863.
[7] Caldwell CB,Mah K,Ung YC,et al.Observer variation in contouring gross tumor volume in patients with poorly defined non-small cell lung tumors on CT:The impact of 18F-FDG-hybrid PET fusion[J].Int J Radiat Oncol Biol Phys,2001,51(4):923-931.
[8] Balogh JB,Caldwell CB,Ung YC,et al.Nterobserver variation in contouring and gross tumor volume in carcinoma of the lung associated with pneumonitis and atelectasis:the impact of 18F-FDG-hybrid pet fusion[J].Int J Radiat Oncol Phys,2000,48(1):128-129.
[9] Nestle U,Walter K,Schmidt S,et al.18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer:High impact in patients with atelectasis[J].Int J Radiat Oncol Biol Phys,1999,44(3):593-597.
[10] Laubenbacher C,Saumweber D,Wagner-Manslau C,et al.Compar-ison of Fluorine-18F luorodeoxyglucose PET,MRI and endoscopy for staging head and neck squamous cell carcinoma[J].J Nucl Med,1995,36(10):1747-1757.
[11] Rahn AN,Baum RP,Adamietz IA,et al.Value of 18F-fluorodeoxyglu-cose positron emission tomography in radiotherapyplanning of head-neck tumors[J].Strahlenther Onkol,1998,174(7):358-364.
[12] Nishioka T,Shiga T,Shirato H,et al.Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas[J].Int J Radiat Oncol Biol Phys,2002,53(4):1051-1057.